<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two representative cases of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> in which <z:mp ids='MP_0002515'>prostaglandin D2</z:mp> (<z:mp ids='MP_0002515'>PGD2</z:mp>) and 6-keto-<z:chebi fb="0" ids="28852">prostaglandin F1 alpha</z:chebi> (6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi>), stable metabolite of prostacyclin (<z:chebi fb="0" ids="15552">PGI2</z:chebi>), were monitored with serial lumbar punctures and detected in cisternal CSF during operations for <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, are reported </plain></SENT>
<SENT sid="1" pm="."><plain>In the case with demonstrated arterial vasospasm, <z:mp ids='MP_0002515'>prostaglandin D2</z:mp> has a concentration trend with characteristic peak related to vasospasm; the synthesis of prostacyclin appears inhibited after the <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In the patient without radiologic evidence of vasospasm, <z:chebi fb="0" ids="32395">arachidonate</z:chebi> metabolite concentration trend appears in a steady-state </plain></SENT>
<SENT sid="3" pm="."><plain>Cisternal <z:mp ids='MP_0002515'>prostaglandin D2</z:mp> concentration in the patient with demonstrated vasospasm is two times the highest lumbar CSF concentration, while 6-keto-<z:chebi fb="0" ids="28852">prostaglandin F1 alpha</z:chebi> concentration is very low </plain></SENT>
<SENT sid="4" pm="."><plain>This suggests the role of the clotting phenomenon and likely confirms the importance of <z:chebi fb="0" ids="32395">arachidonate</z:chebi> metabolites in the genesis of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral arterial spasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>